For some people, the effects of SARS-CoV-2, commonly referred to as COVID-19, extend past the 2-week acute-phase and into the months following initial infection. Those who continue to experience symptoms past the acute-phase are collectively being referred to as “COVID long-haulers,” and their numbers are quickly growing as the virus continues to spread. Long COVID is typically defined by persistent fatigue, shortness of breath, cognitive issues (e.g. brain fog), body aches, coughing, loss of taste and smell, and more that often result in an inability to return to normal levels of functioning (1).
Although the exact cause of long COVID is unclear, researchers believe that ongoing, low-grade inflammation in the brain may play a significant role(1). This helps explain why COVID long haulers experience symptoms such as fatigue, brain fog, and sensory issues as they are linked to issues of the central nervous system. Additionally, preliminary studies suggest that older individuals, women, and those with high BMIs may be at increased risk of experiencing long COVID(2,3). Therefore, therapies that decrease inflammation, such as hyperbaric oxygen therapy, IV therapy, and PEMF therapy may help alleviate symptoms of long COVID by effectively reducing neuroinflammation. Neurofeedback may provide relief of fatigue and brain fog by increasing activation in the brain.
Extivita Therapies for Chronic COVID Syndrome: